Dirk Zboralski - Info zur Person mit Bilder, News & Links



	Anna Kruschinski NOXXON Pharma Eulberg and Axel SDF-1 ASH Annual Meeting Axel Vater Location Christian Maasch Klaus Buchner

News

(1 - 4 von 8

–alle anzeigen

)

PTA-News: DEWB AG Deutsche Effecten- und...

anlegerplus.de

... Idelalisib and Olaptesed Pegol on the Immune Effector Function Mediated by Rituximab Dirk Zboralski, Axel Vater und Anna Kruschinski . Mitarbeiter

Zwei Poster-Präsentationen und zwei Vorträge zu NOXXON-Wirkstoffen...

www.boersennews.de

Phase-I-Studien mit anti-Hepcidin Spiegelmer ® NOX-H94 Wirkmechanismus des anti-SDF-1/CXCL12 Spiegelmers NOX-A12 bei hämatologischen Krebserkrankungen NOXXON …

Myeloma Drug Candidate with Immuno-combo Shows Promise

myelomaresearchnews.com

The poster presentation, titled “CXCL12 Inhibition with NOX-A12 (Olaptesed Pegol) Increases T and NK Cell Infiltration and Synergizes with Immune Checkpoint Blockade and ADCC in Tumour-Stroma Spheroids,” was shown at the conference by senior scientist Dirk Zboralski and hia colleagues, according ...

NOXXON Pharma: Phase IIa Results for Spiegelmer Olaptesed Pegol...

lifesciences.instinctif.com

Dirk Zboralski, Axel Vater and Anna Kruschinski. Members of NOXXON's drug development team and clinical investigators will be at the ASH ...

Netzwerk-Profile

WikiGenes - Dirk Zboralski

www.wikigenes.org

Dirk Zboralski. Department of Internal Medicine. Knappschaftskrankenhaus. IMBL , Ruhr-University of Bochum. Bochum. Germany. [. Name/email ...

Interessen

NOXXON Pharma Announces New Preclinical Data Showing Synergy of Lead...

www.advfn.com

... in a 3D Lymphoma ModelAuthors: Dirk Zboralski, Anna Kruschinski, Dirk Eulberg and Axel VaterLocation & time: 58th ASH Annual Meeting, ...

Bücher

SDF-1 Inhibition Targets the Bone Marrow Niche for Cancer Therapy |...

doaj.org

Information about the open-access article 'SDF-1 Inhibition Targets the Bone Marrow Niche for Cancer Therapy' in DOAJ. DOAJ is an online directory that indexes...

AACR 2016: Abstracts American Association for Cancer...

books.google.de

The AACR Annual Meeting is a must-attend event for cancer researchers and the broader cancer community. This year's theme, "Delivering Cures Through...

Dokumente zum Namen

EBSCOhost | | Divergent mechanisms underlie Smad4-mediated...

web.a.ebscohost.com

Email: Dirk Zboralski - ; Miriam Böckmann - Miriam. ; Marc Zapatka - M.Zapatka@dkfz- heidelberg.de ...

The effects of the anti-hepcidin Spiegelmer NOX-H94 on...

www.scienceopen.com

Authors: Sven Klussmann, Frank Schwoebel, Dirk Zboralski, Heather Humphrey, Christian Maasch, Simone Sell, Klaus Buchner, Werner G.

Wissenschaftliche Veröffentlichungen

Uncoupled responses of Smad4-deficient cancer cells to TNFα result in...

molecular-cancer.biomedcentral.com

Functional loss of the tumor suppressor Smad4 is involved in pancreatic and colorectal carcinogenesis and has been associated with the acquisition of...

Novel compound prevents metastasis of multiple myeloma in mouse...

www.sciencedaily.com

The compound olaptesed pegol can stop multiple myeloma from spreading in mouse models, researchers have found, potentially leading to a new approach in...

Veröffentlichungen allgemein

Oalib search

www.oalib.com

Search Results: of matches for " Dirk Zboralski " All listed articles are free for downloading (OA Articles) ...

Artikel & Meinungen

NOXXON - Was kann die Spiegelmer-Technologie? Beiträge pro Seite

www.wallstreet-online.de

Seite 1 der Diskussion 'NOXXON - Was kann die Spiegelmer-Technologie?' vom im w:o-Forum 'Biotech'.

Sonstiges

NOXXON Pharma Demonstrates Synergies between NOX-A12 and ...

sg.finance.yahoo.com

Authors: Dirk Zboralski, Anna Kruschinski, Dirk Eulberg and Axel Vater Location & time: ESMO Congress 2016, Copenhagen, Denmark,

[PDF] Blockade of SDF-1 after irradiation inhibits tumor recurrences...

www.semanticscholar.org

Dirk Zboralski, Stefan Zöllner, Anna Kruschinski, Sven Klussmann, Lawrence Recht, and J. Martin Brown. Department of Radiation Oncology, Stanford University, Stanford, CA (S-C.L., R.A., S.B.C., F.L., J.S., J.M.B.); Department of Neurology,. Stanford University, Stanford, CA (T.J., M.M., L.R.,); NOXXON Pharma AG, Berlin, ...

Identification and characterization of a mirror-image oligonucleotide...

portlandpress.com

Identification and characterization of a mirror-image oligonucleotide that binds and neutralizes sphingosine 1-phosphate, a central mediator of angiogenesis. Werner G. Purschke, Kai Hoehlig, Klaus Buchner, Dirk Zboralski, Frank Schwoebel, Axel Vater, Sven Klussmann. Biochemical Journal Aug 15, 2014, 462 (1) ; ...

LAMB3 - Labome.Org

www.labome.org

Dirk Zboralski Department of Internal Medicine, Knappschaftskrankenhaus, IMBL, Ruhr University of Bochum, Bochum, Germany BMC Cancer 8: We have reported previously, that Smad4 functions as a positive transcriptional regulator of constitutive and of TGFbeta-induced transcription of all ...

NOXXON presents Updates on Phase II Studies with Olaptesed Pegol...

www.pressebox.com

Noxxon Pharma AG, NOXXON Pharma presented updated interim data sets from two independent clinical Phase IIa studies of the anti-CXCL12/SDF…

NOXXON Pharma AG Release: Phase IIa Results For Spiegelmer Olaptesed...

www.biospace.com

Berlin, Germany and Boston, USA, Germany December NOXXON Pharma will disclose promising data from two independent clinical Phase IIa

NOXXON Pharma AG Presents Updates On Phase II Studies With Olaptesed...

www.biospace.com

Four posters on NOXXON compounds at the European Hematology Association Congress Berlin, Germany June NOXXON Pharma presented updated

Phase IIa Results for Spiegelmer® Olaptesed Pegol (NOX-A12) in MM and...

www.sofinnova.fr

Monday, December 08, 2014, 6:00 PM-8:00 PM, West Building, Level 1 (Moscone Center), Session 625, Publication number: Comparison of Ibrutinib, Idelalisib and Olaptesed Pegol on the Immune Effector Function Mediated by Rituximab Dirk Zboralski, Axel Vater and Anna Kruschinski Members of NOXXON's drug ...

SDF-1 Inhibition Targets the Bone Marrow Niche for Cancer Therapy

www.infona.pl

Aldo M. Roccaro, Antonio Sacco, Werner G. Purschke, Michele Moschetta, Klaus Buchner, Christian Maasch, Dirk Zboralski, Stefan Zöllner, Stefan Vonhoff, Yuji ...

Two Posters and Two Oral Presentations on NOXXON Compounds at

lifesciences.instinctif.com

Aldo M. Roccaro, Antonio Sacco, Marco Ungari, Patricia Maiso, Salomon Manier, Phong Quang, Yosra Aljaway, Dirk Zboralski, Anna Kruschinski, Fabio Facchetti, Giuseppe Rossi, Irene M. Ghobrial. Members of NOXXON's drug development team and collaboration partners will be at the ASH conference to ...

The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with...

mdanderson.elsevierpure.com

Julia Hoellenriegel ; Dirk Zboralski ; Christian Maasch ; Nathalie Y. Rosin ; William G. Wierda ; Michael J. Keating ; Anna Kruschinski ; Jan A.

Zwei Poster-Präsentationen und zwei Vorträge zu NOXXON-Wirkstoffen...

www.pharma-zeitung.de

... Marco Ungari, Patricia Maiso, Salomon Manier, Phong Quang, Yosra Aljaway, Dirk Zboralski, Anna Kruschinski, Fabio Facchetti, Giuseppe Rossi, Irene M. Ghobrial. Mitglieder des Arzneimittelentwicklungsteams von NOXXON und Kollaborationspartner werden an der ASH-Konferenz teilnehmen und den ...

Uncoupled responses of Smad4-deficient cancer cells to TNFalpha...

www.hal.inserm.fr

BACKGROUND: Functional loss of the tumor suppressor Smad4 is involved in pancreatic and colorectal carcinogenesis and has been associated with the acquisition...

The effects of the anti-hepcidin Spiegelmer NOX-H94 on...

ashpublications.org

Key Points. The hepcidin inhibitor NOX-H94, a structured mirror-image RNA oligonucleotide, and its in vitro and in vivo characterization are described.First pub

Verwandte Suchanfragen zu Dirk Zboralski

Axel Vater
Sven Klussmann
Christian Maasch

Dirk Eulberg
Anna Kruschinski
João Fidelis Guimarães

Personen
Vorname "Dirk" (42653)
Name "Zboralski" (29)

sortiert nach Relevanz / Datum

Erweiterte Suche

Dossier exportieren

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Dirk Zboralski Person-Info